MoneyWorks4Me

Lupin informs about analyst meet

19 Jun 2025 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15) of the Listing Regulations, Lupin has informed that the Company will be participating in Nuvama - Specialty Chemicals and Healthcare Investor Conference on June 25, 2025 (In person).

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..